Business Insider11d
Y-mAbs Presents Translational Pharmacokinetics of GD2-SADA from Pretargeted RIT Platform at the SNMMI Mid-Winter and ACNM Annual Meeting
In the first step of pre-targeted radiotherapy, non-radiolabeled GD2-SADA tetramers are infused and bind to GD2-expressing solid tumors, while unbound GD2-SADA protein disassembles into low molecular ...
PipelineReview.com11d
Shionogi Announces Positive Results from Phase 2 Trial of Respiratory Syncytial Virus Oral Antiviral Candidate S-337395
S-337395 is an investigational oral antiviral candidate for RSV infection that inhibits the activity of the L protein, which is essential for virus replication. 1,2 Furthermore, this drug has received ...
Science Daily7d
Blood Clots News
Genetic Carriers for Sickle Cell Disease Have Higher Risks of Blood ... typically receive an injectable blood thinner, low-molecular-weight heparin, to prevent life-threatening blood clots.
C&EN5d
Polymer Molecular Weight Distributions: A Tutorial on Transformations between Number Density, Mass Density, and Linear/Logarithmic Axes
Department of Chemistry, Iowa State University, Ames, Iowa 50011, United States Ames National Laboratory, Iowa State University, Ames, Iowa 50011, United States ...